XS
SM
MD
LG
XL dev

We’re committed to helping you navigate the market impacts of COVID-19. Our news and expert commentary will keep you up-to-date on ever-changing market conditions, and our investor education can equip you with the solutions and strategies you need to weather current market volatility.

Daily Market Update
with JJ Kinahan

5 min read

MU 12 7

(Thursday Market Open) Recent vaccine and stimulus news has mostly sounded promising, but it’s reached the point where investors are asking, “What’s next?” The market can be impatient, but these developments tend to take a while. A vaccine rollout requires months, and it’s still unclear if Congress can actually get something done in this lame-duck session. That means it’s wait-and-see mode on a lot of things. 

Meanwhile, after a few weeks of positive vaccine news that helped push the reality of the crisis into the background a bit, it looks like there’s more focus today on the here and now. The country had its biggest day of diagnoses yesterday and medical experts are saying the U.S. faces a very tough winter. This sort of thing may not be enough to knock the wind out of the rally, but it’s a reminder that a lot of the recent gains were built on hope for something that’s in the future. As we noted yesterday, it’s important not to get caught up in the vaccine euphoria. 

Read article

Knowledge: One of your most valuable assets

Call Us
800-454-9272

Content intended for educational/informational purposes only. Not investment advice, or a recommendation of any security, strategy, or account type.

Be sure to understand all risks involved with each strategy, including commission costs, before attempting to place any trade. Clients must consider all relevant risk factors, including their own personal financial situations, before trading.

adChoicesAdChoices

Market volatility, volume, and system availability may delay account access and trade executions.

Past performance of a security or strategy does not guarantee future results or success.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses. Options trading subject to TD Ameritrade review and approval. Please read Characteristics and Risks of Standardized Options before investing in options.

Supporting documentation for any claims, comparisons, statistics, or other technical data will be supplied upon request.

This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Hong Kong, Japan, Saudi Arabia, Singapore, UK, and the countries of the European Union.

TD Ameritrade, Inc., member FINRA/SIPC, and a subsidiary of TD Ameritrade Holding Corporation. TD Ameritrade Holding Corporation is a wholly owned subsidiary of the Charles Schwab Corporation. TD Ameritrade is a trademark jointly owned by TD Ameritrade IP Company, Inc. and The Toronto-Dominion Bank. © 2020 Charles Schwab & Co., Inc. Member SIPC.

Scroll to Top